rs55840049

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_001009944.3(PKD1):​c.4051C>T​(p.Arg1351Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00096 in 1,610,818 control chromosomes in the GnomAD database, including 13 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1351L) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0047 ( 8 hom., cov: 33)
Exomes 𝑓: 0.00057 ( 5 hom. )

Consequence

PKD1
NM_001009944.3 missense

Scores

7
11

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:6

Conservation

PhyloP100: 0.667

Publications

7 publications found
Variant links:
Genes affected
PKD1 (HGNC:9008): (polycystin 1, transient receptor potential channel interacting) This gene encodes a member of the polycystin protein family. The encoded glycoprotein contains a large N-terminal extracellular region, multiple transmembrane domains and a cytoplasmic C-tail. It is an integral membrane protein that functions as a regulator of calcium permeable cation channels and intracellular calcium homoeostasis. It is also involved in cell-cell/matrix interactions and may modulate G-protein-coupled signal-transduction pathways. It plays a role in renal tubular development, and mutations in this gene cause autosomal dominant polycystic kidney disease type 1 (ADPKD1). ADPKD1 is characterized by the growth of fluid-filled cysts that replace normal renal tissue and result in end-stage renal failure. Splice variants encoding different isoforms have been noted for this gene. Also, six pseudogenes, closely linked in a known duplicated region on chromosome 16p, have been described. [provided by RefSeq, Oct 2008]
PKD1 Gene-Disease associations (from GenCC):
  • autosomal dominant polycystic kidney disease
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • polycystic kidney disease 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • autosomal recessive polycystic kidney disease
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Caroli disease
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.011341393).
BP6
Variant 16-2111116-G-A is Benign according to our data. Variant chr16-2111116-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 225439.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00472 (719/152312) while in subpopulation AFR AF = 0.0163 (679/41570). AF 95% confidence interval is 0.0153. There are 8 homozygotes in GnomAd4. There are 348 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 8 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PKD1NM_001009944.3 linkc.4051C>T p.Arg1351Trp missense_variant Exon 15 of 46 ENST00000262304.9 NP_001009944.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PKD1ENST00000262304.9 linkc.4051C>T p.Arg1351Trp missense_variant Exon 15 of 46 1 NM_001009944.3 ENSP00000262304.4

Frequencies

GnomAD3 genomes
AF:
0.00472
AC:
719
AN:
152194
Hom.:
8
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0164
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00150
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000964
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00383
GnomAD2 exomes
AF:
0.00119
AC:
296
AN:
247814
AF XY:
0.000801
show subpopulations
Gnomad AFR exome
AF:
0.0148
Gnomad AMR exome
AF:
0.000754
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00128
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000629
Gnomad OTH exome
AF:
0.000496
GnomAD4 exome
AF:
0.000567
AC:
827
AN:
1458506
Hom.:
5
Cov.:
36
AF XY:
0.000498
AC XY:
361
AN XY:
725606
show subpopulations
African (AFR)
AF:
0.0163
AC:
546
AN:
33416
American (AMR)
AF:
0.000984
AC:
44
AN:
44702
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26110
East Asian (EAS)
AF:
0.00300
AC:
119
AN:
39694
South Asian (SAS)
AF:
0.0000696
AC:
6
AN:
86170
European-Finnish (FIN)
AF:
0.0000384
AC:
2
AN:
52126
Middle Eastern (MID)
AF:
0.00138
AC:
6
AN:
4350
European-Non Finnish (NFE)
AF:
0.0000306
AC:
34
AN:
1111742
Other (OTH)
AF:
0.00116
AC:
70
AN:
60196
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
61
122
184
245
306
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00472
AC:
719
AN:
152312
Hom.:
8
Cov.:
33
AF XY:
0.00467
AC XY:
348
AN XY:
74470
show subpopulations
African (AFR)
AF:
0.0163
AC:
679
AN:
41570
American (AMR)
AF:
0.00150
AC:
23
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.000966
AC:
5
AN:
5174
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000441
AC:
3
AN:
68022
Other (OTH)
AF:
0.00379
AC:
8
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
40
81
121
162
202
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00165
Hom.:
0
Bravo
AF:
0.00504
ESP6500AA
AF:
0.0128
AC:
56
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.00157
AC:
189
Asia WGS
AF:
0.00202
AC:
7
AN:
3478
EpiCase
AF:
0.00
EpiControl
AF:
0.000119

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:6
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Polycystic kidney disease, adult type Uncertain:1Benign:1
Aug 22, 2023
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 18, 2016
Soonchunhyang University Bucheon Hospital, Soonchunhyang University Medical Center
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:reference population

- -

not specified Benign:2
Jul 30, 2024
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 01, 2025
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: PKD1 c.4051C>T (p.Arg1351Trp) results in a non-conservative amino acid change in the encoded protein sequence. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change. The variant allele was found at a frequency of 0.0012 in 248094 control chromosomes, predominantly at a frequency of 0.015 within the African or African-American subpopulation in the gnomAD database. The observed variant frequency within African or African-American control individuals in the gnomAD database exceeds the estimated maximal expected allele frequency for a pathogenic variant in PKD1 causing PKD1-Biallelic Autosomal Recessive Polycystic Kidney Disease phenotype. c.4051C>T has been observed in individual(s) affected with PKD1-related conditions without strong evidence for causality (Garcia-Gonzalez_2007, Kim_2019, Fujimaru_2018, Rossetti_2007), as well as healthy controls (Kinoshita_2016). These report(s) do not provide unequivocal conclusions about association of the variant with PKD1-Biallelic Autosomal Recessive Polycystic Kidney Disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 29520754, 31740684, 27835667, 17582161, 17574468). ClinVar contains an entry for this variant (Variation ID: 225439). Based on the evidence outlined above, the variant was classified as likely benign. -

Polycystic kidney disease Benign:1
-
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

The PKD1 p.Arg1351Trp variant was identified in 2 of 568 proband chromosomes (frequency: 0.004) from individuals or families with ADPKD (Rossetti_2007, Garcia-Gonzalez_2007). The variant was also identified in dbSNP (ID: rs55840049) “With Uncertain significance allele”, ClinVar (classified uncertain significance by Soonchunhyang University Bucheon Hospital), ADPKD Mutation Database (classified likely neutral), and not in COGR, LOVD 3.0, and PKD1-LOVD. The variant was identified in control databases in 466 of 275234 chromosomes (2 homozygous) at a frequency of 0.002 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database Feb 27, 2017). It was observed in the following populations: African in 396 (1 homozygous) of 23852 chromosomes (freq: 0.02), Other in 7 of 6410 chromosomes (freq: 0.001), Latino in 28 of 34396 chromosomes (freq: 0.0008), European Non-Finnish in 10 of 125168 chromosomes (freq: 0.00008), East Asian in 23 (1 homozygous) of 18814 chromosomes (freq: 0.001), and South Asian in 2 of 30768 chromosomes (freq: 0.00007); it was not observed in the Ashkenazi Jewish and European Finnish populations. The p.Arg1351 residue is conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) provide inconsistent predictions regarding the impact of the variant Trp to the protein; this information is not very predictive of pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) do not predict a difference in splicing. In addition, the variant was identified in our laboratory in 1 individual with ADPKD, co-occurring with a pathogenic PKD1 variant (c.2494dupC, p.Arg832ProfsX40), increasing the likelihood it does not have clinical significance. In summary, based on the above information this variant meets our laboratory criteria to be classified as benign. -

not provided Benign:1
Feb 26, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 22995991, 17574468, 17582161) -

PKD1-related disorder Benign:1
Aug 20, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.099
BayesDel_addAF
Benign
-0.44
T
BayesDel_noAF
Benign
-0.40
CADD
Benign
21
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.66
D;.
Eigen
Benign
-0.18
Eigen_PC
Benign
-0.39
FATHMM_MKL
Benign
0.11
N
LIST_S2
Uncertain
0.88
D;D
MetaRNN
Benign
0.011
T;T
MetaSVM
Benign
-0.80
T
MutationAssessor
Uncertain
2.3
M;M
PhyloP100
0.67
PrimateAI
Benign
0.23
T
PROVEAN
Uncertain
-2.8
D;D
REVEL
Benign
0.14
Sift
Uncertain
0.020
D;D
Sift4G
Uncertain
0.0030
D;D
Polyphen
1.0
D;D
Vest4
0.83
MVP
0.63
ClinPred
0.025
T
GERP RS
2.4
Varity_R
0.081
gMVP
0.58
Mutation Taster
=78/22
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs55840049; hg19: chr16-2161117; API